nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—SLC22A5—dilated cardiomyopathy	0.745	1	CbGaD
Furosemide—ABCC2—Spironolactone—dilated cardiomyopathy	0.116	1	CbGbCtD
Furosemide—CA5B—sinoatrial node—dilated cardiomyopathy	0.0246	0.395	CbGeAlD
Furosemide—Drug eruption—Spironolactone—dilated cardiomyopathy	0.00383	0.0566	CcSEcCtD
Furosemide—CA14—cardiac ventricle—dilated cardiomyopathy	0.00312	0.0501	CbGeAlD
Furosemide—SLCO2A1—cardiac ventricle—dilated cardiomyopathy	0.00259	0.0415	CbGeAlD
Furosemide—SLCO2A1—myocardium—dilated cardiomyopathy	0.00243	0.0391	CbGeAlD
Furosemide—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00241	0.0356	CcSEcCtD
Furosemide—PGD—myocardium—dilated cardiomyopathy	0.00217	0.0348	CbGeAlD
Furosemide—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00216	0.032	CcSEcCtD
Furosemide—CA14—heart—dilated cardiomyopathy	0.00205	0.0329	CbGeAlD
Furosemide—CA14—cardiac atrium—dilated cardiomyopathy	0.00175	0.0281	CbGeAlD
Furosemide—Lethargy—Spironolactone—dilated cardiomyopathy	0.00175	0.0258	CcSEcCtD
Furosemide—SLCO2A1—heart—dilated cardiomyopathy	0.0017	0.0273	CbGeAlD
Furosemide—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00154	0.0227	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00154	0.0227	CcSEcCtD
Furosemide—PGD—heart—dilated cardiomyopathy	0.00151	0.0243	CbGeAlD
Furosemide—CA4—cardiac ventricle—dilated cardiomyopathy	0.00151	0.0242	CbGeAlD
Furosemide—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00146	0.0216	CcSEcCtD
Furosemide—SLCO2A1—cardiac atrium—dilated cardiomyopathy	0.00145	0.0233	CbGeAlD
Furosemide—CA5B—heart—dilated cardiomyopathy	0.00143	0.023	CbGeAlD
Furosemide—CA4—myocardium—dilated cardiomyopathy	0.00142	0.0228	CbGeAlD
Furosemide—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00132	0.0195	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00131	0.0193	CcSEcCtD
Furosemide—Renal failure—Spironolactone—dilated cardiomyopathy	0.0013	0.0191	CcSEcCtD
Furosemide—PGD—cardiac atrium—dilated cardiomyopathy	0.00129	0.0208	CbGeAlD
Furosemide—CA1—heart—dilated cardiomyopathy	0.00127	0.0203	CbGeAlD
Furosemide—CA2—cardiac ventricle—dilated cardiomyopathy	0.00125	0.0201	CbGeAlD
Furosemide—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00123	0.0182	CcSEcCtD
Furosemide—SLC22A5—cardiac ventricle—dilated cardiomyopathy	0.00123	0.0197	CbGeAlD
Furosemide—CA5B—cardiac atrium—dilated cardiomyopathy	0.00123	0.0197	CbGeAlD
Furosemide—CA2—myocardium—dilated cardiomyopathy	0.00118	0.0189	CbGeAlD
Furosemide—SLC22A5—myocardium—dilated cardiomyopathy	0.00116	0.0186	CbGeAlD
Furosemide—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00112	0.0165	CcSEcCtD
Furosemide—ALB—heart—dilated cardiomyopathy	0.00111	0.0179	CbGeAlD
Furosemide—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00109	0.0162	CcSEcCtD
Furosemide—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00106	0.122	CbGpPWpGaD
Furosemide—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00104	0.0153	CcSEcCtD
Furosemide—Gout—Lisinopril—dilated cardiomyopathy	0.00103	0.0152	CcSEcCtD
Furosemide—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00099	0.0146	CcSEcCtD
Furosemide—CA4—heart—dilated cardiomyopathy	0.000989	0.0159	CbGeAlD
Furosemide—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000985	0.0146	CcSEcCtD
Furosemide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000922	0.0136	CcSEcCtD
Furosemide—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00087	0.0128	CcSEcCtD
Furosemide—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000861	0.0127	CcSEcCtD
Furosemide—Confusional state—Spironolactone—dilated cardiomyopathy	0.000848	0.0125	CcSEcCtD
Furosemide—CA4—cardiac atrium—dilated cardiomyopathy	0.000846	0.0136	CbGeAlD
Furosemide—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000841	0.0124	CcSEcCtD
Furosemide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000823	0.0122	CcSEcCtD
Furosemide—CA2—heart—dilated cardiomyopathy	0.00082	0.0132	CbGeAlD
Furosemide—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00081	0.0928	CbGpPWpGaD
Furosemide—SLC22A5—heart—dilated cardiomyopathy	0.000807	0.013	CbGeAlD
Furosemide—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000803	0.0119	CcSEcCtD
Furosemide—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000795	0.0117	CcSEcCtD
Furosemide—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000773	0.0114	CcSEcCtD
Furosemide—Somnolence—Spironolactone—dilated cardiomyopathy	0.000747	0.011	CcSEcCtD
Furosemide—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000726	0.0107	CcSEcCtD
Furosemide—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000721	0.0107	CcSEcCtD
Furosemide—CA2—cardiac atrium—dilated cardiomyopathy	0.000702	0.0113	CbGeAlD
Furosemide—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000701	0.0104	CcSEcCtD
Furosemide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000693	0.0102	CcSEcCtD
Furosemide—SLC22A5—cardiac atrium—dilated cardiomyopathy	0.00069	0.0111	CbGeAlD
Furosemide—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.000676	0.0775	CbGpPWpGaD
Furosemide—Urticaria—Spironolactone—dilated cardiomyopathy	0.000668	0.00986	CcSEcCtD
Furosemide—Irritability—Lisinopril—dilated cardiomyopathy	0.000666	0.00984	CcSEcCtD
Furosemide—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000665	0.00981	CcSEcCtD
Furosemide—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000654	0.00966	CcSEcCtD
Furosemide—Dehydration—Lisinopril—dilated cardiomyopathy	0.000649	0.00959	CcSEcCtD
Furosemide—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000638	0.00942	CcSEcCtD
Furosemide—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000629	0.00928	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000629	0.00928	CcSEcCtD
Furosemide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000619	0.00915	CcSEcCtD
Furosemide—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000597	0.00882	CcSEcCtD
Furosemide—Pruritus—Spironolactone—dilated cardiomyopathy	0.000595	0.00878	CcSEcCtD
Furosemide—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000592	0.00874	CcSEcCtD
Furosemide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000575	0.00849	CcSEcCtD
Furosemide—Dizziness—Spironolactone—dilated cardiomyopathy	0.000556	0.00821	CcSEcCtD
Furosemide—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000551	0.00813	CcSEcCtD
Furosemide—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000544	0.00804	CcSEcCtD
Furosemide—Vomiting—Spironolactone—dilated cardiomyopathy	0.000534	0.00789	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000533	0.00788	CcSEcCtD
Furosemide—Rash—Spironolactone—dilated cardiomyopathy	0.00053	0.00783	CcSEcCtD
Furosemide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00053	0.00782	CcSEcCtD
Furosemide—Renal failure—Lisinopril—dilated cardiomyopathy	0.000529	0.00781	CcSEcCtD
Furosemide—Headache—Spironolactone—dilated cardiomyopathy	0.000527	0.00778	CcSEcCtD
Furosemide—Sweating—Lisinopril—dilated cardiomyopathy	0.000516	0.00762	CcSEcCtD
Furosemide—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000509	0.00751	CcSEcCtD
Furosemide—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000502	0.00741	CcSEcCtD
Furosemide—Nausea—Spironolactone—dilated cardiomyopathy	0.000499	0.00737	CcSEcCtD
Furosemide—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000477	0.00704	CcSEcCtD
Furosemide—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000473	0.00699	CcSEcCtD
Furosemide—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000457	0.00674	CcSEcCtD
Furosemide—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00045	0.00665	CcSEcCtD
Furosemide—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000438	0.00647	CcSEcCtD
Furosemide—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000431	0.00637	CcSEcCtD
Furosemide—Erythema—Lisinopril—dilated cardiomyopathy	0.00042	0.00621	CcSEcCtD
Furosemide—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00042	0.00621	CcSEcCtD
Furosemide—Flatulence—Lisinopril—dilated cardiomyopathy	0.000414	0.00612	CcSEcCtD
Furosemide—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000412	0.00608	CcSEcCtD
Furosemide—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000404	0.00597	CcSEcCtD
Furosemide—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000396	0.00585	CcSEcCtD
Furosemide—Anaemia—Lisinopril—dilated cardiomyopathy	0.000389	0.00574	CcSEcCtD
Furosemide—Vertigo—Lisinopril—dilated cardiomyopathy	0.000378	0.00558	CcSEcCtD
Furosemide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000376	0.00556	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000355	0.00525	CcSEcCtD
Furosemide—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00035	0.00517	CcSEcCtD
Furosemide—Confusional state—Lisinopril—dilated cardiomyopathy	0.000346	0.00511	CcSEcCtD
Furosemide—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000343	0.00507	CcSEcCtD
Furosemide—Shock—Lisinopril—dilated cardiomyopathy	0.000338	0.00499	CcSEcCtD
Furosemide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000336	0.00496	CcSEcCtD
Furosemide—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000333	0.00492	CcSEcCtD
Furosemide—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000332	0.0049	CcSEcCtD
Furosemide—Anorexia—Lisinopril—dilated cardiomyopathy	0.000327	0.00483	CcSEcCtD
Furosemide—Hypotension—Lisinopril—dilated cardiomyopathy	0.000321	0.00473	CcSEcCtD
Furosemide—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000308	0.00455	CcSEcCtD
Furosemide—Somnolence—Lisinopril—dilated cardiomyopathy	0.000305	0.0045	CcSEcCtD
Furosemide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000298	0.0044	CcSEcCtD
Furosemide—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000296	0.00437	CcSEcCtD
Furosemide—Fatigue—Lisinopril—dilated cardiomyopathy	0.000296	0.00437	CcSEcCtD
Furosemide—Pain—Lisinopril—dilated cardiomyopathy	0.000293	0.00433	CcSEcCtD
Furosemide—Constipation—Lisinopril—dilated cardiomyopathy	0.000293	0.00433	CcSEcCtD
Furosemide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000283	0.00418	CcSEcCtD
Furosemide—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000281	0.00414	CcSEcCtD
Furosemide—Urticaria—Lisinopril—dilated cardiomyopathy	0.000273	0.00403	CcSEcCtD
Furosemide—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000271	0.00401	CcSEcCtD
Furosemide—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000271	0.00401	CcSEcCtD
Furosemide—ABCC2—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000269	0.0309	CbGpPWpGaD
Furosemide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000253	0.00373	CcSEcCtD
Furosemide—Asthenia—Lisinopril—dilated cardiomyopathy	0.000246	0.00364	CcSEcCtD
Furosemide—Pruritus—Lisinopril—dilated cardiomyopathy	0.000243	0.00358	CcSEcCtD
Furosemide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000235	0.00347	CcSEcCtD
Furosemide—Dizziness—Lisinopril—dilated cardiomyopathy	0.000227	0.00335	CcSEcCtD
Furosemide—Vomiting—Lisinopril—dilated cardiomyopathy	0.000218	0.00322	CcSEcCtD
Furosemide—Rash—Lisinopril—dilated cardiomyopathy	0.000216	0.00319	CcSEcCtD
Furosemide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000216	0.00319	CcSEcCtD
Furosemide—Headache—Lisinopril—dilated cardiomyopathy	0.000215	0.00317	CcSEcCtD
Furosemide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000213	0.0244	CbGpPWpGaD
Furosemide—Nausea—Lisinopril—dilated cardiomyopathy	0.000204	0.00301	CcSEcCtD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000194	0.0222	CbGpPWpGaD
Furosemide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000162	0.0186	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000162	0.0186	CbGpPWpGaD
Furosemide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000135	0.0155	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000101	0.0116	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.86e-05	0.0113	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.86e-05	0.0113	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	9.67e-05	0.0111	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.17e-05	0.0105	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.46e-05	0.0097	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	8.44e-05	0.00968	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.23e-05	0.00944	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.23e-05	0.00944	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	8.04e-05	0.00922	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.65e-05	0.00877	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	7.37e-05	0.00845	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	7.32e-05	0.00839	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	6.97e-05	0.00799	CbGpPWpGaD
Furosemide—CA14—Metabolism—ANKRD1—dilated cardiomyopathy	6.48e-05	0.00743	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ANKRD1—dilated cardiomyopathy	6.32e-05	0.00724	CbGpPWpGaD
Furosemide—CA6—Metabolism—ANKRD1—dilated cardiomyopathy	6.32e-05	0.00724	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	6.22e-05	0.00713	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	6.15e-05	0.00705	CbGpPWpGaD
Furosemide—CA14—Metabolism—TAZ—dilated cardiomyopathy	6.1e-05	0.00699	CbGpPWpGaD
Furosemide—PGD—Metabolism—ANKRD1—dilated cardiomyopathy	6.1e-05	0.00699	CbGpPWpGaD
Furosemide—CA5A—Metabolism—TAZ—dilated cardiomyopathy	5.94e-05	0.00681	CbGpPWpGaD
Furosemide—CA6—Metabolism—TAZ—dilated cardiomyopathy	5.94e-05	0.00681	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	5.93e-05	0.0068	CbGpPWpGaD
Furosemide—CA7—Metabolism—ANKRD1—dilated cardiomyopathy	5.9e-05	0.00676	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ANKRD1—dilated cardiomyopathy	5.9e-05	0.00676	CbGpPWpGaD
Furosemide—PGD—Metabolism—TAZ—dilated cardiomyopathy	5.73e-05	0.00657	CbGpPWpGaD
Furosemide—CA7—Metabolism—TAZ—dilated cardiomyopathy	5.55e-05	0.00636	CbGpPWpGaD
Furosemide—CA5B—Metabolism—TAZ—dilated cardiomyopathy	5.55e-05	0.00636	CbGpPWpGaD
Furosemide—CA14—Metabolism—SDHA—dilated cardiomyopathy	5.51e-05	0.00632	CbGpPWpGaD
Furosemide—CA12—Metabolism—ANKRD1—dilated cardiomyopathy	5.46e-05	0.00626	CbGpPWpGaD
Furosemide—CA5A—Metabolism—SDHA—dilated cardiomyopathy	5.37e-05	0.00616	CbGpPWpGaD
Furosemide—CA6—Metabolism—SDHA—dilated cardiomyopathy	5.37e-05	0.00616	CbGpPWpGaD
Furosemide—PGD—Metabolism—SDHA—dilated cardiomyopathy	5.18e-05	0.00594	CbGpPWpGaD
Furosemide—CA12—Metabolism—TAZ—dilated cardiomyopathy	5.14e-05	0.00589	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.05e-05	0.00579	CbGpPWpGaD
Furosemide—CA5B—Metabolism—SDHA—dilated cardiomyopathy	5.02e-05	0.00575	CbGpPWpGaD
Furosemide—CA7—Metabolism—SDHA—dilated cardiomyopathy	5.02e-05	0.00575	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.91e-05	0.00563	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.91e-05	0.00563	CbGpPWpGaD
Furosemide—CA12—Metabolism—SDHA—dilated cardiomyopathy	4.65e-05	0.00533	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.57e-05	0.00523	CbGpPWpGaD
Furosemide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	4.55e-05	0.00521	CbGpPWpGaD
Furosemide—CA4—Metabolism—ANKRD1—dilated cardiomyopathy	4.36e-05	0.005	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.26e-05	0.00488	CbGpPWpGaD
Furosemide—CA2—Metabolism—ANKRD1—dilated cardiomyopathy	4.18e-05	0.00479	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.14e-05	0.00475	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	4.11e-05	0.00471	CbGpPWpGaD
Furosemide—CA4—Metabolism—TAZ—dilated cardiomyopathy	4.1e-05	0.0047	CbGpPWpGaD
Furosemide—CA1—Metabolism—ANKRD1—dilated cardiomyopathy	4.01e-05	0.00459	CbGpPWpGaD
Furosemide—CA2—Metabolism—TAZ—dilated cardiomyopathy	3.93e-05	0.0045	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.85e-05	0.00441	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.85e-05	0.00441	CbGpPWpGaD
Furosemide—CA1—Metabolism—TAZ—dilated cardiomyopathy	3.77e-05	0.00432	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.75e-05	0.00429	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.75e-05	0.00429	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	3.74e-05	0.00429	CbGpPWpGaD
Furosemide—CA4—Metabolism—SDHA—dilated cardiomyopathy	3.71e-05	0.00425	CbGpPWpGaD
Furosemide—CA2—Metabolism—SDHA—dilated cardiomyopathy	3.55e-05	0.00407	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—SOD2—dilated cardiomyopathy	3.54e-05	0.00406	CbGpPWpGaD
Furosemide—CA9—Metabolism—ANKRD1—dilated cardiomyopathy	3.52e-05	0.00404	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.48e-05	0.00399	CbGpPWpGaD
Furosemide—CA1—Metabolism—SDHA—dilated cardiomyopathy	3.41e-05	0.0039	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—GPX1—dilated cardiomyopathy	3.38e-05	0.00387	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	3.35e-05	0.00383	CbGpPWpGaD
Furosemide—CA9—Metabolism—TAZ—dilated cardiomyopathy	3.31e-05	0.0038	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	3.25e-05	0.00372	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.21e-05	0.00368	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	3.2e-05	0.00367	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	3.19e-05	0.00366	CbGpPWpGaD
Furosemide—PGD—Disease—NPPA—dilated cardiomyopathy	3.17e-05	0.00363	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.13e-05	0.00358	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.13e-05	0.00358	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.11e-05	0.00357	CbGpPWpGaD
Furosemide—PGD—Disease—PSEN2—dilated cardiomyopathy	3.07e-05	0.00352	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.03e-05	0.00347	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.03e-05	0.00347	CbGpPWpGaD
Furosemide—CA9—Metabolism—SDHA—dilated cardiomyopathy	2.99e-05	0.00343	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.91e-05	0.00333	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.82e-05	0.00323	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	2.76e-05	0.00316	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	2.66e-05	0.00305	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	2.66e-05	0.00305	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	2.54e-05	0.00291	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	2.54e-05	0.00291	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	2.47e-05	0.00283	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.32e-05	0.00266	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2e-05	0.00229	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TTN—dilated cardiomyopathy	1.93e-05	0.00221	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	1.67e-05	0.00192	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	1.67e-05	0.00191	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.67e-05	0.00191	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	1.63e-05	0.00186	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	1.63e-05	0.00186	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	1.56e-05	0.00179	CbGpPWpGaD
Furosemide—PGD—Disease—RAC1—dilated cardiomyopathy	1.54e-05	0.00177	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	1.51e-05	0.00173	CbGpPWpGaD
Furosemide—CA14—Metabolism—GPX1—dilated cardiomyopathy	1.5e-05	0.00172	CbGpPWpGaD
Furosemide—CA6—Metabolism—GPX1—dilated cardiomyopathy	1.46e-05	0.00167	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GPX1—dilated cardiomyopathy	1.46e-05	0.00167	CbGpPWpGaD
Furosemide—CA14—Metabolism—CD36—dilated cardiomyopathy	1.46e-05	0.00167	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VCL—dilated cardiomyopathy	1.42e-05	0.00163	CbGpPWpGaD
Furosemide—CA6—Metabolism—CD36—dilated cardiomyopathy	1.42e-05	0.00163	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CD36—dilated cardiomyopathy	1.42e-05	0.00163	CbGpPWpGaD
Furosemide—PGD—Metabolism—GPX1—dilated cardiomyopathy	1.41e-05	0.00161	CbGpPWpGaD
Furosemide—PGD—Metabolism—CD36—dilated cardiomyopathy	1.37e-05	0.00157	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GPX1—dilated cardiomyopathy	1.36e-05	0.00156	CbGpPWpGaD
Furosemide—CA7—Metabolism—GPX1—dilated cardiomyopathy	1.36e-05	0.00156	CbGpPWpGaD
Furosemide—CA7—Metabolism—CD36—dilated cardiomyopathy	1.33e-05	0.00152	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CD36—dilated cardiomyopathy	1.33e-05	0.00152	CbGpPWpGaD
Furosemide—CA14—Metabolism—AGT—dilated cardiomyopathy	1.31e-05	0.00151	CbGpPWpGaD
Furosemide—CA6—Metabolism—AGT—dilated cardiomyopathy	1.28e-05	0.00147	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AGT—dilated cardiomyopathy	1.28e-05	0.00147	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	1.27e-05	0.00145	CbGpPWpGaD
Furosemide—CA12—Metabolism—GPX1—dilated cardiomyopathy	1.26e-05	0.00145	CbGpPWpGaD
Furosemide—PGD—Metabolism—AGT—dilated cardiomyopathy	1.23e-05	0.00142	CbGpPWpGaD
Furosemide—CA12—Metabolism—CD36—dilated cardiomyopathy	1.23e-05	0.00141	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AGT—dilated cardiomyopathy	1.19e-05	0.00137	CbGpPWpGaD
Furosemide—CA7—Metabolism—AGT—dilated cardiomyopathy	1.19e-05	0.00137	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	1.18e-05	0.00135	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	1.11e-05	0.00128	CbGpPWpGaD
Furosemide—CA12—Metabolism—AGT—dilated cardiomyopathy	1.11e-05	0.00127	CbGpPWpGaD
Furosemide—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	1.1e-05	0.00126	CbGpPWpGaD
Furosemide—ALB—Metabolism—TAZ—dilated cardiomyopathy	1.03e-05	0.00118	CbGpPWpGaD
Furosemide—PGD—Disease—RAF1—dilated cardiomyopathy	1.02e-05	0.00117	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	1.01e-05	0.00115	CbGpPWpGaD
Furosemide—CA4—Metabolism—GPX1—dilated cardiomyopathy	1.01e-05	0.00115	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.96e-06	0.00114	CbGpPWpGaD
Furosemide—CA4—Metabolism—CD36—dilated cardiomyopathy	9.8e-06	0.00112	CbGpPWpGaD
Furosemide—CA2—Metabolism—GPX1—dilated cardiomyopathy	9.65e-06	0.00111	CbGpPWpGaD
Furosemide—CA2—Metabolism—CD36—dilated cardiomyopathy	9.4e-06	0.00108	CbGpPWpGaD
Furosemide—ALB—Metabolism—SDHA—dilated cardiomyopathy	9.34e-06	0.00107	CbGpPWpGaD
Furosemide—CA1—Metabolism—GPX1—dilated cardiomyopathy	9.25e-06	0.00106	CbGpPWpGaD
Furosemide—CA1—Metabolism—CD36—dilated cardiomyopathy	9.01e-06	0.00103	CbGpPWpGaD
Furosemide—CA4—Metabolism—AGT—dilated cardiomyopathy	8.83e-06	0.00101	CbGpPWpGaD
Furosemide—CA2—Metabolism—AGT—dilated cardiomyopathy	8.46e-06	0.00097	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.4e-06	0.000963	CbGpPWpGaD
Furosemide—CA9—Metabolism—GPX1—dilated cardiomyopathy	8.13e-06	0.000932	CbGpPWpGaD
Furosemide—CA1—Metabolism—AGT—dilated cardiomyopathy	8.11e-06	0.00093	CbGpPWpGaD
Furosemide—CA9—Metabolism—CD36—dilated cardiomyopathy	7.92e-06	0.000908	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.6e-06	0.000871	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	7.39e-06	0.000847	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	7.14e-06	0.000819	CbGpPWpGaD
Furosemide—CA9—Metabolism—AGT—dilated cardiomyopathy	7.13e-06	0.000818	CbGpPWpGaD
Furosemide—PGD—Disease—EGFR—dilated cardiomyopathy	7.02e-06	0.000804	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.34e-06	0.000727	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.14e-06	0.000704	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CD36—dilated cardiomyopathy	6.09e-06	0.000698	CbGpPWpGaD
Furosemide—ALB—Hemostasis—RAC1—dilated cardiomyopathy	5.74e-06	0.000658	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.7e-06	0.000653	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.55e-06	0.000636	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.99e-06	0.000572	CbGpPWpGaD
Furosemide—ALB—Hemostasis—RAF1—dilated cardiomyopathy	3.81e-06	0.000436	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.3e-06	0.000378	CbGpPWpGaD
Furosemide—ALB—Metabolism—GPX1—dilated cardiomyopathy	2.54e-06	0.000291	CbGpPWpGaD
Furosemide—ALB—Metabolism—CD36—dilated cardiomyopathy	2.47e-06	0.000283	CbGpPWpGaD
Furosemide—ALB—Metabolism—AGT—dilated cardiomyopathy	2.22e-06	0.000255	CbGpPWpGaD
